CD8A and cancer: Hence, we evaluated furtherly the effects of targeting HSF1-APOJ-STAT3 axis on CD8+ T cells-mediated cancer cells cytotoxicity and verified the enhancement of CD8+ T cells-mediated cytotoxicity when HSF1-APOJ-STAT3 axis was inhibited in HCC cells.